InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.72
(
0.70%
)
US TECH 100
18,318.00
(
0.95%
)
Dow Jones
39,069.59
(
0.01%
)
Brent Oil
82.41
(
0.52%
)
Bitcoin
68,563.88
(
0.08%
)
Post# of 645185
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

AugustaFriends

Send PM Follow Ignore
Followers 1693
Posts 205213
Boards Moderated 11
Alias Born 01/02/2008

AugustaFriends

Re: Crazy Money post# 505777

Wednesday, 06/16/2021 8:24:47 AM

Wednesday, June 16, 2021 8:24:47 AM

Post# of 645185
$APRE Aprea Therapeutics Announces Phase 1/2 Trial of Eprenetapopt + Venetoclax + Azacitidine in TP53 Mutant AML Meets Complete Remission Primary Efficacy Endpoint https://finance.yahoo.com/news/aprea-therapeutics-announces-phase-1-120000137.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @Yahoo

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up